FDA Inspection 1267810 — Island Reproductive Services

Island Reproductive Services — FEI 3011393636

The FDA completed an inspection of Island Reproductive Services on April 17, 2025 in Staten Island, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 17, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Staten Island, NY (United States)